Clinical Trial Update: Sildenafil for Treatment of Choroidal Ischemia [Phase 2]

View source ↗

Summary

This is a completed Phase 2 trial evaluating sildenafil for choroidal ischemia, with results posted in 2025; the study also involves vitelliform macular dystrop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Central Serous Retinopathy
• Choroidal Ischemia
• Retinitis Pigmentosa
• Vitelliform Macular Dystrophy

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Columbia University | Conditions: Choroidal Ischemia, Vitelliform Macular Dystrophy | Phase 2 | Status: COMPLETED | Results posted: 2025-07-04